Biongevity, a subsidiary of BioAro and a global leader in AI-driven health analytics, genomics, and longevity science, ...
The Company intends to use the net proceeds raised from the Offering to support sales growth and for working capital and general corporate purposes as further described in the Company’s offering ...
Launched new corporate website highlighting Shuttle Pharma’s dual approach to Cancer Therapeutics and Diagnostics. Visit https://shuttlepharma.com/ to learn more about how Shuttle Pharma is developing ...
CORAL GABLES, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Acorn Health, a leading provider of applied behavioral analysis therapy, now offers autism spectrum disorder (ASD) testing and diagnostic services ...
Xealth, the leader in enabling digital health at scale, today announced that CEO and Co-founder Mike McSherry will join UPMC ...
In collaborative work, Trethera and the Peter Clark Lab at UCLA have shown that when autoreactive T and B cells divide, they ...
About Spero Therapeutics Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying and developing novel ...
Eighty healthcare organizations, the AMA and all 50 state medical societies wrote congressional leaders urging them to reverse the latest round of Medicare payment cuts and provide physicians with a ...
The Be Wide X-ray solution, powered by IBA’s Rhodotron ® accelerator, will enhance Jabil's portfolio, offering advanced high-scale sterilization technology for a diverse range of medical devices. It ...
Our latest technology, Capryl-Butyrate, is changing the game in the exogenous ketone space as it is versatile enough to support both ketogenic and non-ketogenic lifestyles. It facilitates endogenous ...
Pursuant to section 32 of the Danish Capital Markets Act No. 198 of February 26, 2024, it is hereby announced, that the total nominal value of Genmab A/S' share capital after the capital increase is ...
Positive Adjusted EBITDA – Precipio reports (unaudited) Adjusted EBITDA of $0.4M for Q4-2024. Adjusted EBITDA is a non-GAAP metric that comprises EBITDA, less non-cash stock-based compensation expense ...